APA (7th ed.) Citation

Amagai, R., Fujimura, T., Kambayashi, Y., Ohuchi, K., Yamazaki, E., Hashimoto, A., & Asano, Y. (2023). Recurrent, Tumor Mutation Burden-High, Cutaneous Angiosarcoma of the Scalp Treated with Pembrolizumab. Case Reports in Oncology, 16(1), 1490. https://doi.org/10.1159/000534657

Chicago Style (17th ed.) Citation

Amagai, Ryo, Taku Fujimura, Yumi Kambayashi, Kentaro Ohuchi, Emi Yamazaki, Akira Hashimoto, and Yoshihide Asano. "Recurrent, Tumor Mutation Burden-High, Cutaneous Angiosarcoma of the Scalp Treated with Pembrolizumab." Case Reports in Oncology 16, no. 1 (2023): 1490. https://doi.org/10.1159/000534657.

MLA (9th ed.) Citation

Amagai, Ryo, et al. "Recurrent, Tumor Mutation Burden-High, Cutaneous Angiosarcoma of the Scalp Treated with Pembrolizumab." Case Reports in Oncology, vol. 16, no. 1, 2023, p. 1490, https://doi.org/10.1159/000534657.